Study on Dietary Intake Levels of Iodine for 3-6 Years Old Pre-school Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-6
SponsorChen Wen

About this trial

Iodine as an essential trace element for human, both excessive and insufficient intake would be harmful for human health. As susceptible population, children will be more sensitive to adverse effects caused by inadequate intake of iodine since they are at the peak of growth and development. Meanwhile, there are few direct evidence to establish dietary intakes levels of iodine for 3-6 years old pre-school children.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

for children with mild malnutrition: hemoglobin <110g / L, or weight for age <P50 according to the Chinese 2009 child growth and development reference standard, or BMI z score <-1 according to the WHO Child Growth Assessment Software (version 3.2.2 ) ; have not been treated for thyroid disease; have not used amiodarone and other drugs (including iodine supplements) during the investigation; have no major diseases ,chronic diseases and family history.

for children with good nutritional status: healthy,-1 <BMI z score <1; have not been treated for thyroid disease; have not used amiodarone and other drugs (including iodine supplements) during the investigation; have no major diseases ,chronic diseases and family history;

Disqualifiers

None

Trial population

3-6 years old pre-school children are the research subjects. They were recruited in Tianjin and Shandong.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • no intervention

    Other intervention

    Natural exposure of iodine

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

urinary iodine concentration

μg/L

Time frame
2 weeks
2

diet iodine intake

μg/day

Time frame
2 weeks
3

urinary iodine excretion

μg/day

Time frame
2 weeks
4

thyroglobulin antibody

IU/mL

Time frame
2 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chen Wen

Lead sponsor

Tianjin Medical University

Sponsor institution

Shandong Institute for Endemic Disease Control and Research

Collaborator